Investor relations

press releases

08/16/2022

PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification

08/16/2022

PainReform Provides Business Update for the Second Quarter of 2022

05/17/2022

PainReform Provides Business Update for the First Quarter of 2022

04/12/2022

PainReform to Present at The Noble Capital Markets’ Eighteenth Annual Investor Conference on April 20th

03/21/2022

PainReform to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest onMarch 28th – 30th 

03/17/2022

PainReform Provides Year-End Business Update; On track to Commence Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief in the Second Half of 2022